BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8101959)

  • 1. [The evaluation of cellular proliferating activity in gastric carcinoma with the proliferating cell nuclear antigen (PCNA) expressive rate: its fundamental examination of the immunohistochemical procedures and its clinical applications].
    Nakano H; Namatame K; Nakayoshi A; Kumada K
    Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):580-92. PubMed ID: 8101959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma.
    Kunimoto Y; Nakamura T; Ohno M; Kuroda Y
    Oncol Rep; 2004 Dec; 12(6):1163-7. PubMed ID: 15547732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms.
    Teague K; el-Naggar A
    Cytometry; 1994 Jan; 15(1):21-7. PubMed ID: 7909288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis].
    Li N
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):34-6. PubMed ID: 8101481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of low dose CDDP/5-fluorouracil therapy on PCNA labeling index and TS inhibition rate of gastric cancer].
    Kosaka T; Sugaya J; Yoshida S; Takano Y; Nakano Y; Akiyama T; Kiriyama M; Tomita F; Saito H; Kita I
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():205-8. PubMed ID: 7611790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of proliferating cell nuclear antigen(PCNA) in biopsy and autopsy specimens of gastric carcinoma.
    He XB; Ii K; Muguruma N; Hayashi S; Ito S
    J Med Invest; 1998 Feb; 44(3-4):149-53. PubMed ID: 9597802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
    Gorczyca W; Kram A; Tuziak T; Darzynkiewicz Z; Melamed MR
    Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of proliferating cell nuclear antigen (PCNA) labeling rate and malignancy in gastric cancer: preliminary report].
    Yonemura Y; Yamaguchi A; Kaji M; Fushida S; Tugawa K; Fonseca L; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1992 Jun; 93(6):661. PubMed ID: 1352850
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical detection of proliferative cells.
    Mokrý J; Nĕmecek S
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
    Takamura H; Yonemura Y; Hirono Y; Ninomiya I; Sahara H; Tsugawa K; Matsumoto H; Sugiyama K; Fujimura T; Nishimura G
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):788-95. PubMed ID: 8098198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of proliferating activity in gastric carcinoma stained by proliferating cell nuclear antigen (PCNA): preliminary report].
    Nakano H; Namatame K; Suzuki T; Nakayoshi A; Kumada K
    Nihon Geka Gakkai Zasshi; 1992 Feb; 93(2):216. PubMed ID: 1348104
    [No Abstract]   [Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.
    Hall PA; Levison DA; Woods AL; Yu CC; Kellock DB; Watkins JA; Barnes DM; Gillett CE; Camplejohn R; Dover R
    J Pathol; 1990 Dec; 162(4):285-94. PubMed ID: 1981239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in endometrial carcinoma with argyrophil cells.
    Ueda G; Sawada M; Ogawa H; Tanizawa O; Tsujimoto M
    Gynecol Oncol; 1993 Mar; 48(3):314-6. PubMed ID: 8096489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
    Oshiro Y; Fukuda T; Tsuneyoshi M
    Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
    Krauss JS; Pantazis CG; Chandler FW
    Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.